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Abstract: Brain-derived neurotrophic factor (BDNF) is a mediator of exercise and nutrition-induced
neural plasticity. In children with cerebral palsy (CP), neuromuscular deficits and mobility impairment
have a negative impact on their physical activity level and nutritional status, but whether these
children have reduced BDNF concentrations is unknown. Therefore, the aim of the present study
was to investigate the plasma BDNF concentration, nutritional status, and physical activity level
in children with mild to severe CP. Blood sampling, dietary registration, and questionnaires were
completed for children with mild CP (gross motor function classification system (GMFCS) I–II, n = 31,
age 10.6 ± 0.6 years), severe CP (GMFCS IV–V, n = 14, age 10.9 ± 1.1 years) and typically developed
(TD) children (n = 22, age 10.9 ± 0.6 years). Children with severe CP had ~40% lower plasma BDNF
concentration than TD children (p < 0.05). Furthermore, children with severe CP had lower daily
physical activity level than TD children (p < 0.01), and a daily intake of energy, n-3 fatty acids,
and dietary fibers that was only ~50% of TD (p > 0.001). Reduced plasma BDNF concentrations were
observed in children with severe CP. This may be of significance for optimal neural growth and
plasticity. This was observed together with low physical activity levels and a suboptimal intake of
energy, n-3 fatty acids, and dietary fibers.
Keywords: dietary registration; maximal oxygen uptake; blood sampling; energy; dietary fibers; n-3
fatty acids; DHA; plasticity; cerebral palsy
1. Introduction
There has been an intense focus on daily physical activity level and nutritional status in children
the last two decades. This is partly because of strong associations between sedentary behavior,
suboptimal nutrition, and childhood obesity [1], but also because physical activity and nutritional
status can influence brain plasticity and function as well as learning and memory [2,3]. In children
with cerebral palsy, neuromuscular deficit and mobility impairment have a negative impact on these
parameters. Cerebral palsy (CP) is an umbrella term, which covers lesions of the developing brain prior
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to or around the time of birth causing an impaired development of movement abilities and frequently
also perceptual and cognitive problems [4]. CP is linked to impaired activity-dependent differentiation
and the establishment of connectivity in neural networks during development [5–8]. Studies have
reported lower levels of daily physical activity [9] and physical fitness [10–12] in children with CP
compared to typically developed (TD) control children. In addition, a high risk of malnutrition due to
the insufficient intake of dietary energy has been identified in children with CP in both high [13] and
low/middle-income [14–16] countries.
The n-3 fatty acid docosahexaenoic acid (DHA) is one of the most promising dietary components
in relation to cognitive development in rodents and humans [3]. Studies in rodents have reported
that DHA is able to promote synaptogenesis and improve learning and memory abilities [3,17–21].
In addition, DHA has been shown to increase the production of brain-derived neurotrophic factor
(BDNF) [19], which is a member of neurotrophic family of proteins, and the most abundant
neurotrophic factor in the brain [22]. Neurological development of the brain is highly dependent on
BDNF due to its vital role in the growth, survival, and proliferation of distinct neuronal populations in
the central nervous system [23–25]. In addition, the intake of energy [26,27] and dietary fibers [28,29]
has also been shown to influence BDNF production and cognitive development.
In children, studies have shown positive impacts of exercise on cognitive function such as greater
attention and working memory [30,31], faster speed at information processing [30], and higher scores
in academic achievement tests [32,33] in physically fit children when compared to lower fit peers.
BDNF has been suggested to be one of the mediators responsible for the exercise-induced increase
in cognitive performance [34]. However, the exact link between BDNF production and improved
cognitive performance has not been fully clarified, and is especially difficult to establish in humans,
partly because it is not possible to measure brain levels of BDNF. Aerobic exercise and resistance
training in adults have been shown to increase serum BDNF concentration in some [35,36], but not all
studies [37]. Interestingly, in rodents, DHA supplementation seems to have synergistic effects with
exercise/physical activity on the production of BDNF and on learning and memory [3,38,39].
The combination of low physical activity, low energy intake, and malnutrition in children with
CP may be accompanied by insufficient production of BDNF and thereby suboptimal conditions for
neurological development. However, this remains to be elucidated. The aim of the present study was
to determine age–body weight z-scores, energy and nutritional intake (including intake of n-3 fatty
acids and fibers), daily physical activity level, physical fitness level (when feasible), and circulating
concentrations of BDNF and other blood parameters in children with mild and severe CP and a group
of TD children.
2. Materials and Methods
2.1. Subjects
A total of 22 typically developed (TD) control children (13 boys and nine girls, mean age
10.9 ± 0.6 years), 31 children with mild CP (19 boys and 12 girls, mean age 10.6 ± 0.6 years),
and 14 children with severe CP (seven boys and seven girls, mean age 10.9 ± 1.1 years) were
recruited for the study. Children with CP were recruited in collaboration with the Elsass Institute,
2920 Charlottenlund, Denmark, Geelsgårdskolen, 2830 Virum, Denmark and Department of
Orthopedic Surgery, Copenhagen University Hospital Hvidovre, 2650 Hvidovre, Denmark. Children
with CP were classified using the gross motor function classification system (GMFCS) [40], with mild
CP ranging from level I to II (CP I–II) and severe CP ranging from level IV to V (CP IV–V).
The subjects performed dietary and activity registration (completion rate: TD: 73%, CP I–II: 42%,
CP IV–V: n = 79%) and blood sampling (completion rate: TD: 68%, CP I–II: n = 42%, CP IV–V: 79%).
Furthermore, TD and CP I–II performed maximal oxygen uptake testing (completion rate: TD: 50%,
CP I–II: 35%).
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2.2. Ethics Approval and Consent to Participate
The children and their parents gave informed written and oral consent to the study, which was
approved by the local ethics committee for the Copenhagen area (H-B-2009-017). The study was
performed in accordance with the Helsinki Declaration.
2.3. Measurements of Height and Body Weight
A digital physician scale with a height rod was used to measure body weight and height in TD,
CP I–II, and CP IV–V, when feasible. In non-ambulatory children, height was measured with a height
rod in a supine lying position on an examination bed, and weight was measured with a digital scale
weight (Guldmann, Aarhus, Denmark) by lifting the child in a lift sheet. The children were measured
while fasting in the morning whenever feasible.
2.4. Diet and Activity Registration
Four to eight days of individual dietary registrations, where all food items and beverages were
weighed within 1 g of accuracy, were completed to examine the daily habitual diet composition
and energy intake. Information and instructions were provided verbally and in writing to the
children, a family member, and employees of the child’s school. Representative days for diet
recording were planned together with each child and family member. Intake of macronutrients,
micronutrients, and energy were calculated using the computer program Vitakost (Vitakost, Kolding,
Denmark). The children and their parents also filled out physical activity questionnaires (type,
duration, and intensity of daily activities) on the same days as diet registrations were performed.
Nordic Nutrition Recommendations 2012 [41] were used as a reference for the recommended intake of
energy, macronutrients, and micronutrients.
2.5. Maximal Oxygen Uptake
Physical fitness level was evaluated in CP I–II and TD by measurements of maximal oxygen uptake
(VO2 max) during an incremental treadmill running test to exhaustion, as previously described [42].
In brief, the protocol started with 1 min of running at an individual maximal running speed of
9–11.5 km/h on a slope of 0% followed by a stepwise 1% incline every 1 min until exhaustion.
The criteria for reaching exhaustion were: respiratory exchange ratio (RER) >1.00, a plateau in VO2
despite increasing slope, and inability to continue running despite verbal encouragement. During all of
the tests, the children were secured with a safety belt (Teddy pants, Liko, Sweden) and breathed through
pediatric masks adapted to their faces. Respiratory gas exchanges were measured breath-by-breath
using an automatic gas analysis system (CPX MedGraphics, Saint Paul, USA) to determine oxygen
uptake (VO2) and respiratory exchange ratio (RER).
2.6. Blood Sampling
Children arrived in the morning in a fasting state (12 h) and after, 15 min of rest in a sitting or
lying position, blood was drawn from an antecubital vein. Plasma and serum samples were frozen at
−30 and −80 ◦C, respectively, until further analysis.
Blood samples (n = 7) were taken from children with CP undergoing surgery during anesthesia.
Blood samples were kept on ice during the surgery and centrifuged at 3000 rpm. Then, plasma was
transferred into Eppendorf tubes and stored at −80 ◦C until subsequent analysis.
2.7. Analysis
Plasma glucose concentration was measured using ABL815 (Radiometer Medical A/S, Copenhagen,
Denmark). Quantitative determination of insulin in plasma was performed by sandwich-type immunoassay
(Triolab, Alpco, New Hampshire, USA). Plasma BDNF concentration was measured by a commercially
available kit (Cat. No. CYT306, Chemicon International Chomikine) by ELISA (Millipore, Corporation,
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Massachusetts, USA). Serum sodium and potassium were determined by flame photometer, FLM3
(Radiometer, Brønshøj, Denmark), and total plasma cholesterol by spectrophotometric analysis. All analyses
were performed in accordance with the recommendations of the manufacturer.
2.8. Calculations
As recommended by World Health Organization (WHO), z-scores must be used as a global
reference for the definition of malnutrition. Data from Rigshospitalet (www.v\T1\aekstkurver.dk)
were used as growth standards describing the development of healthy children in optimal conditions
in Denmark. Thus, we identified the deviation of growth of Danish children with CP from those of
healthy Danish children in optimal conditions. SD-score was calculated as (X/M)L − 1/L*S, if L 6= 0
with X being the value of interest (height, body weight, and body mass index (BMI)) and L, M, and S
being values obtained from the standards depending on age and gender.
Resting energy expenditure (REE) was estimated in accordance with Henry 2005 [43]. Information
from the activity questionnaires was used to estimate a physical activity (PAL) score in accordance
with Nordic Nutrition Recommendations 2012 [41]. Daily energy expenditure (EE) was calculated as
PAL*REE.
The homeostasis model assessment insulin resistance index (HOMA-IR) was calculated as fasting
insulin (µU/mL)*fasting plasma glucose (mmol/L)/22.5 [44].
2.9. Statistics
Data are expressed as means ± standard error of the mean (SEM). All data were analyzed using
SigmaPlot (version 11.0, SYSTAT Software, San Jose, CA, USA). One-way analysis of variance (ANOVA)
tests with Tukey post-hoc test were performed on results comparing all three groups (TD, CP I–II,
and CP VI-V) except when testing for group differences in the regression slopes. Here, one-way analysis
of covariance (ANCOVA) tests with Tukey post-hoc test were performed. In the treadmill testing,
unpaired t-tests were performed as results included only two groups (TD and CP I–II). A significance
of P < 0.05 was chosen in all cases.
3. Results
3.1. Subject Characteristics
The subject characteristics of all included children are presented in Table 1. The control group of
TD children was comparable to healthy Danish children in relation to age–height, age–body weight,
and age–body mass index (BMI) z-scores. There was no difference in age between TD, CP I–II, and CP
IV–V. Height, body weight, and BMI in average and as z-scores did not differ between TD and CP I–II.
In contrast, CP IV–V had ~10% lower height (p < 0.05) and ~33% lower body weight (p < 0.01) than
TD. The height and body weight of CP IV–V were also lower than CP I–II (p < 0.001). Furthermore,
age–height, age–body weight, and age–BMI z-scores of CP IV–V were remarkably low and significantly
lower than TD (p < 0.05) and CP I–II (p < 0.05).
The relationships between age and weight in the groups are illustrated in Figure 1.
When evaluating the effect of age on body weight by one-way ANCOVA with Tukey post-hoc test, the
slope of CP IV–V was significantly different from TD (p < 0.001) and CP I–II (p < 0.001), illustrating
a lower increase in body weight with increasing age in CP IV–V than TD and CP I–II. There was
no difference in the slope between TD and CP I–II. These data illustrate a deviating relationship
between age and body weight in children with severe CP, and thus indicate an abnormal growth rate
in this group.
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Table 1. Subject characteristics.
TD CP I–II CP IV–V
Number of children 22 31 14
Boys/girls 13/9 19/12 7/7
Age (years) 10.9 ± 0.6 10.6 ± 0.6 10.9 ± 1.0
Height (cm) 147 ± 3 152 ± 3 131 ± 5 *,###
Age–Height (z-score) 0.1 ± 0.2 0.0 ± 0.2 −2.4 ± 0.7 ***,##
Body weight (kg) 40 ± 2 45 ± 3 27 ± 2 **,###
Age–Body weight (z-score) 0.2 ± 0.2 0.2 ± 0.3 −4.0 ± 1.2 **,###
BMI (kg/m2) 18 ± 1 19 ± 0.6 16 ± 1 (*),##
Age–BMI (z-score) 0.1 ± 0.3 0.3 ± 0.2 −1.2 ± 0.5 *,##
Data are obtained from typically developed (TD) children and children with cerebral palsy (CP) at gross motor
function classification system (GMFCS) level I–II and IV–V. Data are means ± SEM. One-way ANOVA with Tukey
post=hoc test was performed. (*) p = 0.1, * p < 0.05, ** p < 0.01 *** p < 0.001 vs. TD, ## p < 0.05, ### p < 0.001 vs. CP I–II.
BMI: body mass index.
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3.3. Evaluation of Physical Fitness Capacity  
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running on a treadmill in CP I–II and TD (Table 2). In CP I–II, VO2 max averaged 51.4 ± 1.5 mL/min/kg 
and was not different from TD. Furthermore, there was no group difference in the weekly hours of 
sport-related activities (Table 2), based on questionnaires, indicating an active CP I–II group. At the 
Figure 1. Scatter plot illustrating the r lationship between age and body weight in TD children (n = 22)
and chil ren with CP at GMFCS level I–II (n = 31) and IV–V (n = 14). A one-way ANCOVA with Tukey
post-hoc te was performed.
3.2. Resting Energy Expenditure (REE) and Daily Energy Expenditure (EE)
Daily physical activity level and body composition were similar in TD and CP I–II. REE averaged
to 5.6 ± 0.2 megajoule (MJ)/day in TD and CP II, with no difference between the groups. In contrast,
REE in CP IV–V was 4.51 ± 0.2 MJ/day, which was 20% lower than TD and CP I–II (p < 0.05). EE was
7.49 ± 0.4 MJ/day in CP IV–V, which was significantly lower by ~30% than TD (9.63 ± 0.3 MJ/day)
and CP I–II (9.59 ± 0.3 MJ/day) (p < 0.001).
3.3. Evaluation of Physical Fitness Capacity
To investigate physical fitness level, maximal oxygen consumption was measured during running
on a treadmill in CP I–II and TD (Table 2). In CP I–II, VO2 max averaged 51.4 ± 1.5 mL/min/kg
and was not different from TD. Furthermore, there was no group difference in the weekly hours of
sport-related activities (Table 2), based on questionnaires, indicating an active CP I–II group. At the
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end of the treadmill test, the criteria for exhaustion were reached, and the average maximal heart rate
and respiratory exchange ratio (RER) were equally high in both groups (Table 2).
Table 2. Physical fitness capacity determined as maximal oxygen uptake (VO2 max).
TD CP I–II
Sport-related activities (hours per week) 2.5 ± 0.8 2.3 ± 0.5
Heart rate max 197 ± 3 197 ± 3
RER 1.2 ± 0.02 1.1 ± 0.02
VO2 max (L/min) 2.0 ± 0.2 2.2 ± 0.1
VO2 max (mL/min/kg) 52.5 ± 2.5 51.4 ± 1.5
Testing was performed in TD children (n = 11) and children with CP at GMFCS level I–II (n = 11). Data are
means ± SEM. RER: respiratory exchange ratio.
3.4. Eating Patterns
In a subgroup of children that performed dietary registrations, different eating behaviors were
observed depending on the group (Figure 2). In TD (n = 16) and CP I–II (n = 13), no eating difficulties
were observed. In contrast, normal eating behavior was only observed in ~9% of CP IV–V (n = 11).
In this group, ~27% of the children were eating orally, but with difficulties, and ~64% of the children
were eating partially or completely through a feeding tube (Figure 2).
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3.5. aily Intake of Energy and acronutrients
The daily energy intake in T as on average ~9 J and ithin the ordic utrition
eco endations [41] (Table 3). CP I–II did not differ in daily energy intake from TD, whereas
CP IV–V had lower daily energy intake than reco mended, and ~40% lower daily energy intake than
both T (p < 0.001) and P I–II (p < 0.01) (Table 3). hen evaluating the relationship bet een age and
energy intake, there was a significantly different slope in CP IV–V compared to TD (p < 0.05, Figure 3),
illustrating a lower increase in energy intake with increasing age in CP IV–V than TD.
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Table 3. Daily intake of energy and macronutrients.
TD CP I–II CP IV–V RI a
Energy Intake (KJ) 8983 ± 633 8144 ± 540 5165 ± 291 ***,## Girls: 8600 Boys: 9300
Macronutrients
Protein (E%) 16.7 ± 0.6 15.4 ± 0.6 15.3 ± 1.4 10–20
Protein (g/kg BW) 2.22 ± 0.14 1.81 ± 0.14 1.77 ± 0.53 0.75
Carbohydrates (E%) 52.5 ± 1.4 50.3 ± 0.9 46.9 ± 1.9 * 45–60
Dietary fibers (E%) 2.6 ± 0.2 2.4 ± 0.1 1.5 ± 0.5 *
Dietary fibers (g) 28.5 ± 1.8 23.9 ± 2.0 9.6 ± 2.9 ***,# >10
Dietary fibers (g/MJ) 3.3 ± 0.2 2.9 ± 0.1 2.0 ± 0.4 * 2–3
Fat (E%) 28.3 ± 1.4 32.0 ± 1.0 36.2 ± 10.9 * 25–40
Saturated fatty acid
(E%) 10.1 ± 0.7 10.5 ± 2.5 11.1 ± 3.4 <10
Monounsaturated
fatty acid (E%) 8.0 ± 0.5 8.9 ± 0.5 12.0 ± 3.8 10→20
Polyunsaturated fatty
acid (E%) 3.7 ± 0.2 4.6 ± 0.4 5.1 ± 1.6 5→10
n-3 fatty acids (g) 1.5 ± 0.2 1.6 ± 0.2 0.6 ± 0.1 ***
Cholesterol (mg) 198 ± 22 213 ± 22 103 ± 26 *,# <300
Added sugar (E%) 8.9 ± 1.3 8.8 ± 1.8 4.9 ± 3.9 ***,## <10
Data are given by an average of three to eight independent days of 24-h dietary weighing in TD children (n = 16)
and children with CP at GMFCS level I–II (n = 13) and IV–V (n = 11). Data are means ± SEM. One-way ANOVA
with Tukey post-hoc test was performed. * p < 0.05, *** p < 0.001 vs. TD # p < 0.05, ## p < 0.01 vs. CP I–II. BW: body
weight. E%: percentages of total energy intake. a RI: Recommended intake for a child aged 10–11 years from Nordic
Nutrition Recommendations (NNR) 2012 [41].Nutrients 2017, 9, x FOR PEER REVIEW  8 of 17 
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The intake of macronutrients is listed in Table 3. There were no group differences in protein intake
(~16 E%) or daily protein intake expressed as gram per kg of body weight (BW). Dietary fat intake
(E%) was ~8 E% higher in CP IV–V than TD (p = 0.01). Importantly, daily intake of n-3 fatty acids was
~45% lower in CP IV–V than TD and CP I–II (p < 0.001). Four children in CP I–II and two children
in CP IV–V supplemented th ir diet with n-3 fatty acid supplements. Including l e tation,
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the average intake of n-3 fatty acids was 1.8 ± 0.2 in CP I–II and 0.7 ± 0.1 in CP IV–V. Daily fiber intake
was lower in CP IV–V than TD when expressed as E% (p < 0.05), in grams (p < 0.001), and in grams
per MJ energy intake (p < 0.05). CP IV–V had lower daily intake of cholesterol than TD and CP I–II
(p < 0.05) and lower daily intake of added sugar than TD (p < 0.001) and CP I–II (p < 0.01).
3.6. Daily Intake of Vitamins and Minerals
The intake of vitamins and minerals are listed in Table 4. In TD, the daily intake of the majority of
vitamins and minerals were within recommended levels [41], when dietary supplements were excluded.
There were no statistical differences in daily intake of vitamins and minerals between TD and CP I–II.
Children with CP IV–V had sufficient intake of some vitamins and minerals despite low energy intake.
However, the daily intake of vitamin B12, ascorbic acid, beta-carotene, phosphorus, and potassium
were significantly lower in CP IV–V than TD. Interestingly, CP IV–V had a significantly higher daily
intake of vitamin D than TD and CP I–II (p < 0.01). However, without dietary supplementation,
the majority of children in all groups did not meet the recommended level of vitamin D intake (TD:
~88%, CP I–II: ~93%, CP IV–V: ~55%). Children who ingested vitamin D supplementation (TD: n = 5,
CP I–II: n = 6, CP IV–V: n = 5) met the recommended intake when supplementation was included,
and thus, the percentage of children who did not meet the recommended intake of vitamin D was
reduced when adding dietary supplementation (TD: ~56%, CP I–II: ~46%, CP IV–V: ~27%).
Table 4. Daily intake of micronutrients.
TD (n = 16) CP I–II (n = 13) CP IV–V (n = 11)
RI a
Dietary
Intake
Incl.
Dietary
Supplements
Dietary
Intake
Incl.
Dietary
Supplements
Dietary Intake
Incl.
Dietary
Supplements
Vitamins
Vitamin A (RE (µg)) 945 ± 124 1045 ± 130 737 ± 146 890 ± 167 865 ± 214 1083 ± 205 600
Vitamin D (µg) 3.3 ± 0.9 6.4 ± 1.3 3.0 ± 1.0 11.3 ± 4.4 8.7 ± 1.7 **,## 20.0 ± 5.6 10
Vitamin E (aTE (mg)) 6.5 ± 0.6 7.6 ± 1.1 8.0 ± 1.1 10.7 ± 2.0 8.8 ± 1.7 11.4 ± 1.6 7
Vitamin B1 (thiamin) (mg) 1.4 ± 0.1 1.6 ± 0.1 1.2 ± 0.1 1.5 ± 0.2 1.2 ± 0.2 1.5 ± 0.2 1.2
Vitamin B2 (riboflavin) (mg) 1.5 ± 0.1 1.7 ± 0.1 1.4 ± 0.2 1.8 ± 0.3 1.2 ± 0.2 1.6 ± 0.2 1.4
Vitamin B3 (niacin) (mg) 15.0 ± 1.8 17.9 ± 1.8 13.0 ± 2.3 17.5 ± 2.4 12.1 ± 1.8 16.6 ± 2.0 Girls: 14,Boys: 16
Vitamin B6 (mg) 1.6 ± 0.2 1.9 ± 0.2 1.4 ± 0.1 1.8 ± 0.2 1.4 ± 0.2 1.8 ± 0.2 1.3
Vitamin B12 (µg) 4.4 ± 0.4 9.2 ± 1.5 4.5 ± 0.6 5.2 ± 0.7 2.5 ± 0.4 **,## 3.1 ± 0.8 2
Vitamin C (mg) 120 ± 17 137 ± 15 115 ± 8 143 ± 18 94 ± 12 116 ± 13 50
Ascorbic acid (mg) 70 ± 3 70 ± 9 27 ± 8 *,##
β-carotene (µg) 7241 ± 1391 3707 ± 790 1879 ± 698 **
Minerals
Calcium (mg) 960 ± 88 979 ± 82 794 ± 117 842 ± 117 751 ± 102 987 ± 113 900
Phosphorus (mg) 1359 ± 86 1359 ± 85 1163 ± 116 1174 ± 114 675 ± 60 ***,## 675 ± 59 700
Potassium (mg) 2827 ± 224 2503 ± 212 1294 ± 163 ***,# Girls: 2900,Boys: 3300
Magnesium (mg) 328 ± 24 335 ± 24 272 ± 25 295 ± 33 187 ± 17 190 ± 16 280
Iron (mg) 9.5 ± 0.7 11.2 ± 0.9 7.9 ± 0.5 11.9 ± 1.9 10.1 ± 1.7 14.1 ± 1.7 11
Zinc (mg) 10.7 ± 0.9 11.3 ± 0.8 8.6 ± 0.8 10.7 ± 1.2 8.6 ± 1.4 11.3 ± 1.3 11
Copper (mg) 2.7 ± 0.4 2.8 ± 0.4 2.1 ± 0.3 2.3 ± 0.4 2.8 ± 0.5 3.0 ± 0.5 0.7
Iodine (µg) 137 ± 13 155 ± 12 138 ± 22 178 ± 29 108 ± 14 148 ± 21 150
Selenium (µg) 46 ± 5 51 ± 5 38 ± 4 52 ± 7 40 ± 7 54 ± 7 40
Data are means of three to eight independent days of 24-h dietary weighing in TD children (n = 16) and children
with CP at GMFCS level I–II (n = 13) and IV–V (n = 11). Dietary supplementation was ingested in five TD, seven CP
I–II, and five CP IV–V. Data are means ± SEM. One-way ANOVA with Tukey post-hoc test was performed between
dietary intake without supplementation. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. TD. # p < 0.05, ## p < 0.01 vs. CP I–II.
RI a: Recommended intake for a child aged 10–11 years from NNR 2012 [41].
3.7. Fasting Blood Parameters
The fasting plasma BDNF concentration averaged ~6500 pg/mL in TD and CP1-II (Figure 4).
Notably, in CP IV–V, fasting plasma BDNF concentration was ~4000 pg/mL, which was ~40% lower
than in TD (p < 0.05).
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Figure 4. Fasting plasma brain-derived neurotrophic factor (BDNF) concentration in TD children (n = 15)
and children with CP at GMFCS level I–II (n = 13) and IV–V (n = 11). Data are means ± SEM. One-way
ANOVA with Tukey post-hoc test was performed. * p < 0.05 compared to TD.
Fasting plasma glucose concentration averaged 5 mmol/L in all groups (Table 5). Furthermore,
there were no statistically significant differences in fasting insulin concentration or HOMA-IR, but the
variations were high, especially in CP IV–V. There was no difference between TD and CP I–II regarding
fasting profile. In contrast, CP IV–V had significantly lower concentrations of serum sodium than TD
(p < 0.05, Table 5).
Table 5. Fasting blood values.
TD CP I–II CP IV–V
Plasma glucose (mmol/L) 4.9 ± 0.1 5.0 ± 0.2 5.0 ± 0.1
Plasma insulin (µlU/mL) 5.8 ± 0.8 7.5 ± 1.0 9.0 ± 3.0
HOMA-IR 1.3 ± 0.2 1.9 ± 0.1 2.01 ± 0.7
Plasma hematocrit (%) 43.8 ± 1.0 43.3 ± 1.2 42.2 ± 1.4
Plasm hemoglobin (mmol/L) 8.9 ± 0.2 8.8 ± 0.3 8.5 ± 0.3
Serum sodium (mmol/L) 133 ± 1.0 130 ± 1 125 ± 2 *
Serum potassium (mmol/L) 3.88 ± 0.12 4.05 ± 0.08 4.34 ± 0.26
Plasma total Cholesterol (mmol/L) 3.90 ± 0.18 3.64 ± 0.18 3.57 ± 0.17
Blood sampling is performed in TD children (n = 15) and children with CP at GMFCS level I–II (n = 13) and IV–V
(n = 11). Data are means ± SEM. One-way ANOVA with Tukey post-hoc test was performed. * p < 0.05 vs. TD. BMI:
body mass index. BDNF: Brain-derived neurotrophic factor. HOMA-IR: Homeostasis model assessment insulin
resistance index.
4. Discussion
In the present study, we observed a deviating relationship between age and body weight in
children with severe CP compared to children with mild CP and TD children, which was supported by
a ~33% lower average body weight in children with severe CP than age-matched TD and age-body
weight Z-scores in an average−4 of standard scores. In contrast to children with severe CP, we observed
normal growth parameters in children with mild CP when compared to TD children and judged by age
Z-scores. The low body weight in children with severe CP may be related to low energy intake rather
than high energy expenditure. Low energy intake in children with severe CP resulted in an insufficient
intake of n-3 fatty acids and dietary fibers. Interestingly, in children with severe CP, but not mild CP,
plasma BDNF concentration was ~40% lower than in TD children. This could be of significance for
optimal neural growth and plasticity.
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In the included children with severe CP, eating difficulties were highly represented, with more
than 60% of the children eating completely or partially by feeding tube, whereas no eating difficulties
were observed in children with mild CP or TD children. The eating difficulties could explain the
observed low energy intake in the group with severe CP. Although the dietary record method has some
limitations, such as for example risks of underreporting, the energy intake in the children with severe
CP was 40% lower than TD children. Furthermore, low energy intake in children with severe CP is
a notion that is supported by others [13,45]. The present data, together with the existing knowledge
linking low energy intake to poor linear growth in children with CP [46–50], indicate that the low
energy intake with age underlies the non-linear growth in children with severe CP in the present study.
A high risk of inadequate energy for growth in children with severe CP is a concern even though
the present group of severe CP had significantly lower resting and daily energy expenditure than
children with mild CP and TD children. However, it should be noted that daily energy expenditure was
estimated based on activity questionnaires and body weight and height, which has some limitations.
Although the resting energy expenditure and daily energy expenditure of the TD group was not
different from previous reports in children within a similar age range (review in [51]), it can be
speculated that increased muscle activity, due to the involuntary movements in children with severe
CP, may increase resting energy expenditure and energy expenditure in different positions, and thus
makes the low energy intake even more detrimental. In fact, it was recently reported that children with
moderate CP have 40% higher energy expenditure during standing than their TD peers, which was
measured as oxygen consumption [52]. Furthermore, in a study by Verschuren et al. (2014), energy
expenditure during different positions was measured by indirect calorimetry in children with a variety
of CP classifications. Despite the small sample sizes, the authors were able to detect increased energy
expenditure during standing with increasing disability [53]. In line with this, children with CP have a
higher energy [11] and oxygen [54] cost for walking compared to TD, and the oxygen cost increases
with increasing disability [55]. Collectively, these data indicate elevated energy expenditure during
different positions in children with severe CP and the present data on energy expenditure, in this
group, may likely be underestimated.
Another consequence of the low energy intake in children with severe CP was the low intake
of n-3 fatty acids, which was ~45% lower than the TD group. The n-3 fatty acid DHA has been
shown to be an important component of the cell membrane of neurons of the central nervous system,
where it may provide fluidity of the membrane at synaptic regions [56]. This may facilitate synaptic
plasticity through mechanisms such as increased integration and the movement of receptors and other
membrane proteins that are essential for establishing new synapses [17,57]. DHA has also been shown
to increase the production of BDNF, which is one of the neurotrophic factors involved in synaptic
plasticity [19,38,58]. It is probably these mechanisms which are responsible for the positive effect of
DHA supplementation on learning and memory, which has been documented in rodents [38,59,60].
Human studies have shown mixed results [42,61–64]. The low intake of n-3 fatty acids in children with
severe CP was observed despite n-3 fatty acid supplements in many of the feeding tube products.
In the present study, low dietary fiber intake was observed in children with severe CP compared
to TD children. A recent study reported increased plasma BDNF concentration as a result of fiber-rich
dietary intake in healthy adults [28]. Furthermore, in healthy children, dietary fiber intake has been
positively related to nutrient energy intake [65], and attentional inhibition as resisting distractions
and habits to maintain focus [29], suggesting an important role of dietary fibers in children with
CP. In addition, in this group of children with severe CP, the physical activity level was very low.
BDNF has been suggested to be one of the mediators responsible for the exercise-induced increase in
cognitive performance [34], and DHA supplementation has been shown to act synergistically with
exercise/physical activity on the production of BDNF and on the learning and memory abilities of
rodents [3,38,39]. On the basis of these observations, it can be speculated whether the reduction in n-3
fatty acid and dietary fiber intake per se and/or combined with low physical activity level contribute
to the 40% lower plasma BDNF concentration in this group of children with severe CP compared to
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TD children. Supporting this is the adequate intake of n-3 fatty acids, dietary fiber, and daily physical
activity level, together with similar high plasma BDNF concentrations in children with mild CP and
TD children. In the literature, there is currently only limited data on circulating BDNF concentration in
children with CP. In one study, three-year-old children with moderate to severe CP did not differ in
neonatal blood BDNF concentration from TD children [66]. However, this study did not account for
nutrient status. In order to unravel the effects of physical activity and different nutrients on plasma
BDNF concentrations in TD children, and especially in children with CP, more studies are needed.
BDNF can cross the blood–brain barrier, and blood drawn from the antecubital vein is believed
to reflect the BDNF levels in the brain [67]. However, although the major production of BDNF is
in the brain, peripheral tissue such as skeletal muscle [68] and brown and white adipose tissue [69]
can also produce BDNF and may add to the concentration of circulating BDNF. Although no direct
measurements of muscle mass or fat mass were performed in the present study, the markedly low
body weight in children with severe CP can presumably partly be ascribed to a lower muscle mass and
fat mass, as reported by others [70]. This may contribute to the low circulating BDNF concentration in
this group. One possible consequence of low plasma BDNF concentration in children with severe CP
is an increased risk of insufficient brain BDNF concentration, which may be of significance for optimal
neural growth and plasticity. Thus, the observational data from the present study suggest optimizing
BNDF-facilitating nutrients and physical activity to increase the conditions for brain development.
The suboptimal nutrition that characterized children with severe CP, in terms of low energy intake
and insufficient intake of n-3 fatty acids and dietary fibers, identifies a challenge for caregivers and
parents and nutritional counseling, and feeding strategies are necessary. One strategy to increase
energy intake is by increasing the use of tube feeding. In a study by Sullivan et al. 2005, feeding by
gastrostomy in children with CP resulted in increased energy intake and body weight [71]. That tube
feeding is superior to oral feeding in terms of increasing body weight is supported by comparative
studies on children with CP, reporting a higher incidence of children with CP who were low in
age-related weight when orally fed compared to gastronomy tube fed [72,73]. However, the orally
fed children, in one of these studies, had a higher intake of dietary fibers than the gastronomy tube
children [72]. This highlights the importance of choosing the right tube-feeding product.
The low intake of n-3 fatty acids in children with severe CP identifies a need for an increased intake
of n3-rich products or dietary supplementations such as DHA supplementation. DHA supplementation
has previously been shown to increase circulating DHA in healthy preschool children [42], and might
therefore be one recommended solution in order to ensure sufficient levels in children with severe CP.
Low dietary fiber intake in children has been reported as a risk factor for chronic constipation [74],
which is a comorbidity that is common in CP [75,76]. The normalization of dietary fiber intake is
recommended as a first strategy for treating constipation in children with CP [75]. Thus, in children
suffering from constipation, it is important to ensure sufficient dietary fibers to the diet and tube
products to improve the function of the gastrointestinal system.
In contrast to children with severe CP, children with mild CP displayed a similar nutritional intake
as their TD peers in terms of comparable levels of energy intake and dietary intake of micronutrients
and macronutrients. One explanation may be normal feeding behavior without any feeding difficulties.
Another explanation could be that this group had comparable body composition, daily activity levels,
and weekly sport activities as the TD group. In order to investigate whether this normal activity level
of children with mild CP also translated to normal physical fitness, we measured VO2-max by treadmill
testing to exhaustion in children with mild CP and TD children. VO2-max is considered a good marker
of physical fitness status, and school-based programs have illustrated that increased daily physical
activity can increase VO2-max in children and adolescents [77–79]. VO2-max in the control group was
on average 52 min/min/kg, which is comparable to [80,81] or higher than [82,83] other studies on
adolescent or typically developed children, but lower than athletic children [80]. Interestingly, children
with mild CP did not differ in VO2-max compared to their TD peers in the present study, which is in
contrast to other studies reporting a lower VO2-max in children with CP than healthy peers [10–12].
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Differences in the level of daily physical activity could explain these differences. No measure of daily
physically activity level was reported in two of the studies [10,11], and more children in the control
group than in the CP group classified themselves as physically “active” and “very active” in the third
study [12]. Also, when comparing the absolute VO2-max values with the CP groups across these
studies, VO2-max in the present CP group (51.4 ± 1.5) was markedly higher than previously reported
(28.7–42 mL/min/kg [10–12]), supporting an active CP group in the present study. These data indicate
that active children with mild CP have a similar physical fitness status to TD children, which highlights
the importance of encouraging children with CP to be physically active.
5. Conclusions
A significantly reduced plasma BDNF concentration was observed in children with low body
weight and severe CP. This was observed together with low physical activity level and a suboptimal
intake of energy, n-3 fatty acids, and dietary fibers. The suboptimal dietary intake might be due
to eating difficulties. In contrast to children with severe CP, body weight, eating behavior, dietary
intake, physical activity level, and physical fitness status was normal in children with mild CP,
and fasting plasma BDNF concentration was similar to their TD peers. Together, these data suggest
that individually-based dietary counseling should be recommended for children with severe CP, with a
focus on n-3 fatty acids supplementation and the sufficient intake of energy and dietary fibers, as such
actions may optimize neural growth and plasticity.
Author Contributions: Conceptualization, S.L.H., J.L., J.B.N., and B.K.; formal analysis, S.L.H. and J.L.;
investigation, S.L.H., J.L., L.T.P., F.L.H., M.J., and J.P.; writing—original draft preparation, S.L.H., J.B.N., and B.K.;
writing—review and editing, S.L.H., J.L., L.T.P., F.J.H., M.J., J.P., J.B.N., and B.K.; visualization, S.L.H. and J.L.;
supervision, S.L.H., J.L., and B.K.; project administration, S.L.H., J.L., and M.J.
Funding: This research was funded by a grant from the Elsass foundation.
Acknowledgments: We are grateful to all the children and their families who participated in this study. We also
acknowledge The Elsass Institute for providing testing facilities and Geelsgårdskolen for their great help and
assistance. We would also like to thank Christian Wong, Department of Orthopedic Surgery, Copenhagen
University Hospital Hvidovre, for help with recruitment. Furthermore, we would like to thank Camilla Thomsen
and the staff at the Biochemical department at Copenhagen University Hospital for valuable help during
the blood sampling. We also acknowledge Irene Bech Nielsen, Molecular Physiology, NEXS, KU for expert
technical assistance.
Conflicts of Interest: There are no conflict of interest to declare.
References
1. Stein, D.; Weinberger-Litman, S.L.; Latzer, Y. Psychosocial perspectives and the issue of prevention in
childhood obesity. Front Public Health 2014, 2, 104. [CrossRef] [PubMed]
2. Fedewa, A.L.; Ahn, S. The effects of physical activity and physical fitness on children’s achievement and
cognitive outcomes: A meta-analysis. Res. Q. Exerc. Sport 2011, 82, 521–535. [CrossRef] [PubMed]
3. Gomez-Pinilla, F. Brain foods: The effects of nutrients on brain function. Nat. Rev. Neurosci. 2008, 9, 568–578.
[CrossRef] [PubMed]
4. Rosenbaum, P.; Paneth, N.; Leviton, A.; Goldstein, M.; Bax, M.; Damiano, D.; Dan, B.; Jacobsson, B. A report:
The definition and classification of cerebral palsy April 2006. Dev. Med. Child Neurol. Suppl. 2007, 109, 8–14.
[PubMed]
5. Martin, J.H.; Chakrabarty, S.; Friel, K.M. Harnessing activity-dependent plasticity to repair the damaged
corticospinal tract in an animal model of cerebral palsy. Dev. Med. Child Neurol. 2011, 53 (Suppl. 4), 9–13.
[CrossRef]
6. Martin, J.H.; Friel, K.M.; Salimi, I.; Chakrabarty, S. Activity- and use-dependent plasticity of the developing
corticospinal system. Neurosci. Biobehav. Rev. 2007, 31, 1125–1135. [CrossRef]
7. Stolp, H.; Neuhaus, A.; Sundramoorthi, R.; Molnar, Z. The Long and the Short of it: Gene and Environment
Interactions During Early Cortical Development and Consequences for Long-Term Neurological Disease.
Front Psychiatry 2012, 3, 50. [CrossRef]
Nutrients 2019, 11, 620 13 of 16
8. Eyre, J.A. Corticospinal tract development and its plasticity after perinatal injury. Neurosci. Biobehav. Rev.
2007, 31, 1136–1149. [CrossRef]
9. Van den Berg-Emons, H.J.; Saris, W.H.; de Barbanson, D.C.; Westerterp, K.R.; Huson, A.; van Baak, M.A.
Daily physical activity of schoolchildren with spastic diplegia and of healthy control subjects. J. Pediatr. 1995,
127, 578–584. [CrossRef]
10. Verschuren, O.; Takken, T. Aerobic capacity in children and adolescents with cerebral palsy. Res. Dev. Disabil.
2010, 31, 1352–1357. [CrossRef]
11. Garcia, C.C.; Alcocer-Gamboa, A.; Ruiz, M.P.; Caballero, I.M.; Faigenbaum, A.D.; Esteve-Lanao, J.; Saiz, B.M.;
Lorenzo, T.M.; Lara, S.L. Metabolic, cardiorespiratory, and neuromuscular fitness performance in children
with cerebral palsy: A comparison with healthy youth. J. Exerc. Rehabil. 2016, 12, 124–131. [CrossRef]
[PubMed]
12. Hoofwijk, M.; Unnithan, V.B.; Bar-Or, O. Maximal treadmill performance in children with cerebral palsy.
Pediatr. Exerc. Sci. 1995, 7, 305–315. [CrossRef]
13. Sullivan, P.B.; Juszczak, E.; Lambert, B.R.; Rose, M.; Ford-Adams, M.E.; Johnson, A. Impact of feeding
problems on nutritional intake and growth: Oxford Feeding Study II. Dev. Med. Child Neurol. 2002, 44,
461–467. [CrossRef] [PubMed]
14. Jahan, I.; Muhit, M.; Karim, T.; Smithers-Sheedy, H.; Novak, I.; Jones, C.; Badawi, N.; Khandaker, G. What
makes children with cerebral palsy vulnerable to malnutrition? Findings from the Bangladesh cerebral palsy
register (BCPR). Disabil. Rehabil. 2018, 1–8. [CrossRef]
15. Herrera-Anaya, E.; Angarita-Fonseca, A.; Herrera-Galindo, V.M.; Martinez-Marin, R.D.;
Rodriguez-Bayona, C.N. Association between gross motor function and nutritional status in children with
cerebral palsy: A cross-sectional study from Colombia. Dev. Med. Child Neurol. 2016, 58, 936–941. [CrossRef]
16. Polack, S.; Adams, M.; O’banion, D.; Baltussen, M.; Asante, S.; Kerac, M.; Gladstone, M.; Zuurmond, M.
Children with cerebral palsy in Ghana: Malnutrition, feeding challenges, and caregiver quality of life.
Dev. Med. Child Neurol. 2018, 60, 914–921. [CrossRef]
17. Wurtman, R.J.; Cansev, M.; Ulus, I.H. Synapse formation is enhanced by oral administration of uridine and
DHA, the circulating precursors of brain phosphatides. J. Nutr. Health Aging 2009, 13, 189–197. [CrossRef]
18. Wurtman, R.J.; Cansev, M.; Sakamoto, T.; Ulus, I.H. Use of phosphatide precursors to promote synaptogenesis.
Annu. Rev. Nutr. 2009, 29, 59–87. [CrossRef]
19. Wu, A.; Ying, Z.; Gomez-Pinilla, F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative
damage, and counteract learning disability after traumatic brain injury in rats. J. Neurotrauma 2004, 21,
1457–1467. [CrossRef]
20. Jiang, L.H.; Shi, Y.; Wang, L.S.; Yang, Z.R. The influence of orally administered docosahexaenoic acid on
cognitive ability in aged mice. J. Nutr. Biochem. 2009, 20, 735–741. [CrossRef]
21. Sakamoto, T.; Cansev, M.; Wurtman, R.J. Oral supplementation with docosahexaenoic acid and
uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007,
1182, 50–59. [CrossRef] [PubMed]
22. Hofer, M.; Pagliusi, S.R.; Hohn, A.; Leibrock, J.; Barde, Y.A. Regional distribution of brain-derived
neurotrophic factor mRNA in the adult mouse brain. EMBO J. 1990, 9, 2459–2464. [CrossRef] [PubMed]
23. Acheson, A.; Conover, J.C.; Fandl, J.P.; DeChiara, T.M.; Russell, M.; Thadani, A.; Squinto, S.P.;
Yancopoulos, G.D.; Lindsay, R.M. A BDNF autocrine loop in adult sensory neurons prevents cell death.
Nature 1995, 374, 450–453. [CrossRef] [PubMed]
24. Numakawa, T.; Suzuki, S.; Kumamaru, E.; Adachi, N.; Richards, M.; Kunugi, H. BDNF function and
intracellular signaling in neurons. Histol. Histopathol. 2010, 25, 237–258. [PubMed]
25. Zhang, Q.; Liu, G.; Wu, Y.; Sha, H.; Zhang, P.; Jia, J. BDNF promotes EGF-induced proliferation and migration
of human fetal neural stem/progenitor cells via the PI3K/Akt pathway. Molecules 2011, 16, 10146–10156.
[CrossRef] [PubMed]
26. Beydoun, M.A.; Lhotsky, A.; Wang, Y.; Dal, F.G.; An, Y.; Metter, E.J.; Ferrucci, L.; O’Brien, R.; Zonderman, A.B.
Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer’s disease.
Am. J. Epidemiol. 2008, 168, 1179–1189. [CrossRef] [PubMed]
27. Monteleone, P.; Tortorella, A.; Martiadis, V.; Serritella, C.; Fuschino, A.; Maj, M. Opposite changes in the
serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom. Med. 2004, 66, 744–748.
[CrossRef]
Nutrients 2019, 11, 620 14 of 16
28. Sandberg, J.C.; Bjorck, I.M.E.; Nilsson, A.C. Increased Plasma Brain-Derived Neurotrophic Factor 10.5 h
after Intake of Whole Grain Rye-Based Products in Healthy Subjects. Nutrients 2018, 10, 1097. [CrossRef]
[PubMed]
29. Khan, N.A.; Raine, L.B.; Drollette, E.S.; Scudder, M.R.; Kramer, A.F.; Hillman, C.H. Dietary fiber is positively
associated with cognitive control among prepubertal children. J. Nutr. 2015, 145, 143–149. [CrossRef]
[PubMed]
30. Hillman, C.H.; Castelli, D.M.; Buck, S.M. Aerobic fitness and neurocognitive function in healthy
preadolescent children. Med. Sci. Sports Exerc. 2005, 37, 1967–1974. [CrossRef]
31. Hillman, C.H.; Buck, S.M.; Themanson, J.R.; Pontifex, M.B.; Castelli, D.M. Aerobic fitness and cognitive
development: Event-related brain potential and task performance indices of executive control in
preadolescent children. Dev. Psychol. 2009, 45, 114–129. [CrossRef] [PubMed]
32. Coe, D.P.; Peterson, T.; Blair, C.; Schutten, M.C.; Peddie, H. Physical fitness, academic achievement,
and socioeconomic status in school-aged youth. J. Sch. Health 2013, 83, 500–507. [CrossRef] [PubMed]
33. Donnelly, J.E.; Greene, J.L.; Gibson, C.A.; Smith, B.K.; Washburn, R.A.; Sullivan, D.K.; DuBose, K.; Mayo, M.S.;
Schmelzle, K.H.; Ryan, J.J.; et al. Physical Activity Across the Curriculum (PAAC): A randomized controlled
trial to promote physical activity and diminish overweight and obesity in elementary school children.
Prev. Med. 2009, 49, 336–341. [CrossRef] [PubMed]
34. Cotman, C.W.; Berchtold, N.C.; Christie, L.A. Exercise builds brain health: Key roles of growth factor
cascades and inflammation. Trends Neurosci. 2007, 30, 464–472. [CrossRef]
35. Araya, A.V.; Orellana, X.; Godoy, D.; Soto, L.; Fiedler, J. Effect of exercise on circulating levels of brain-derived
neurotrophic factor (BDNF) in overweight and obese subjects. Horm. Metab. Res. 2013, 45, 541–544.
[CrossRef]
36. Kuo, F.C.; Lee, C.H.; Hsieh, C.H.; Kuo, P.; Chen, Y.C.; Hung, Y.J. Lifestyle modification and behavior therapy
effectively reduce body weight and increase serum level of brain-derived neurotrophic factor in obese
non-diabetic patients with schizophrenia. Psychiatry Res. 2013, 209, 150–154. [CrossRef]
37. Swift, D.L.; Johannsen, N.M.; Myers, V.H.; Earnest, C.P.; Smits, J.A.; Blair, S.N.; Church, T.S. The effect of
exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2
diabetes. PLoS ONE 2012, 7, e42785. [CrossRef]
38. Wu, A.; Ying, Z.; Gomez-Pinilla, F. Docosahexaenoic acid dietary supplementation enhances the effects of
exercise on synaptic plasticity and cognition. Neuroscience 2008, 155, 751–759. [CrossRef]
39. Wu, A.; Ying, Z.; Gomez-Pinilla, F. Exercise facilitates the action of dietary DHA on functional recovery after
brain trauma. Neuroscience 2013, 248, 655–663. [CrossRef]
40. Palisano, R.J.; Copeland, W.P.; Galuppi, B.E. Performance of physical activities by adolescents with cerebral
palsy. Phys. Ther. 2007, 87, 77–87. [CrossRef]
41. Nordic Council of Ministers. Nordic Nutrition Recommendations 2012, Integrating Nutrition and Physical Activity;
Nordic council of Ministers: Copenhagen, Denmark, 2012.
42. Hansen, S.; Ritterband-Rosenbaum, A.; Voigt, C.; Hellgren, L.; Sørensen, A.; Jacobsen, C.; Greve, L.;
Jørgensen, K.; Bilde, P.; Kiens, B.; et al. Supplementation of docosahexaenoc acid (DHA), vitamin D3
and uridine in combination with six weeks of cognitive and motor training in prepubecent children: A pilot
study. BMC Nutr. 2017. [CrossRef]
43. Henry, C.J. Basal metabolic rate studies in humans: Measurement and development of new equations.
Public Health Nutr. 2005, 8, 1133–1152. [CrossRef]
44. Matthews, D.R.; Hosker, J.P.; Rudenski, A.S.; Naylor, B.A.; Treacher, D.F.; Turner, R.C. Homeostasis model
assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations
in man. Diabetologia 1985, 28, 412–419. [CrossRef] [PubMed]
45. Karagiozoglou-Lampoudi, T.; Daskalou, E.; Vargiami, E.; Zafeiriou, D. Identification of feeding risk factors
for impaired nutrition status in paediatric patients with cerebral palsy. Acta Paediatr. 2012, 101, 649–654.
[CrossRef]
46. Dahlseng, M.O.; Finbraten, A.K.; Juliusson, P.B.; Skranes, J.; Andersen, G.; Vik, T. Feeding problems, growth
and nutritional status in children with cerebral palsy. Acta Paediatr. 2012, 101, 92–98. [CrossRef]
47. Thommessen, M.; Kase, B.F.; Riis, G.; Heiberg, A. The impact of feeding problems on growth and energy
intake in children with cerebral palsy. Eur. J. Clin. Nutr. 1991, 45, 479–487.
Nutrients 2019, 11, 620 15 of 16
48. Stallings, V.A.; Cronk, C.E.; Zemel, B.S.; Charney, E.B. Body composition in children with spastic quadriplegic
cerebral palsy. J. Pediatr. 1995, 126, 833–839. [CrossRef]
49. Krick, J.; van Duyn, M.A. The relationship between oral-motor involvement and growth: A pilot study in a
pediatric population with cerebral palsy. J. Am. Diet. Assoc. 1984, 84, 555–559.
50. Reilly, S.; Skuse, D. Characteristics and management of feeding problems of young children with cerebral
palsy. Dev. Med. Child Neurol. 1992, 34, 379–388. [CrossRef]
51. Cheng, H.L.; Amatoury, M.; Steinbeck, K. Energy expenditure and intake during puberty in healthy nonobese
adolescents: A systematic review. Am. J. Clin. Nutr. 2016, 104, 1061–1074. [CrossRef]
52. Saxena, S.; Kumaran, S.; Rao, B.K. Energy expenditure during standing in children with cerebral palsy:
A brief report1. J. Pediatr. Rehabil. Med. 2016, 9, 241–245. [CrossRef]
53. Verschuren, O.; Peterson, M.D.; Leferink, S.; Darrah, J. Muscle activation and energy-requirements for
varying postures in children and adolescents with cerebral palsy. J. Pediatr. 2014, 165, 1011–1016. [CrossRef]
54. Unnithan, V.B.; Dowling, J.J.; Frost, G.; Bar-Or, O. Role of cocontraction in the O2 cost of walking in children
with cerebral palsy. Med. Sci. Sports Exerc. 1996, 28, 1498–1504. [CrossRef] [PubMed]
55. Johnston, T.E.; Moore, S.E.; Quinn, L.T.; Smith, B.T. Energy cost of walking in children with cerebral palsy:
Relation to the Gross Motor Function Classification System. Dev. Med. Child Neurol. 2004, 46, 34–38.
[CrossRef]
56. Glomset, J.A. Role of docosahexaenoic acid in neuronal plasma membranes. Sci. STKE 2006, 2006, e6.
[CrossRef] [PubMed]
57. Wurtman, R.J. A nutrient combination that can affect synapse formation. Nutrients 2014, 6, 1701–1710.
[CrossRef] [PubMed]
58. Rathod, R.S.; Khaire, A.A.; Kale, A.A.; Joshi, S.R. Beneficial effects of omega-3 fatty acids and vitamin
B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive
performance in the second-generation Wistar rats. Biofactors 2015, 41, 261–272. [CrossRef]
59. Holguin, S.; Huang, Y.; Liu, J.; Wurtman, R. Chronic administration of DHA and UMP improves the impaired
memory of environmentally impoverished rats. Behav. Brain Res. 2008, 191, 11–16. [CrossRef]
60. Holguin, S.; Martinez, J.; Chow, C.; Wurtman, R. Dietary uridine enhances the improvement in learning and
memory produced by administering DHA to gerbils. FASEB J. 2008, 22, 3938–3946. [CrossRef]
61. Yurko-Mauro, K.; Alexander, D.D.; van Elswyk, M.E. Docosahexaenoic acid and adult memory: A systematic
review and meta-analysis. PLoS ONE 2015, 10, e0120391. [CrossRef]
62. Stonehouse, W.; Conlon, C.A.; Podd, J.; Hill, S.R.; Minihane, A.M.; Haskell, C.; Kennedy, D. DHA
supplementation improved both memory and reaction time in healthy young adults: A randomized
controlled trial. Am. J. Clin. Nutr. 2013, 97, 1134–1143. [CrossRef] [PubMed]
63. Cooper, R.E.; Tye, C.; Kuntsi, J.; Vassos, E.; Asherson, P. Omega-3 polyunsaturated fatty acid supplementation
and cognition: A systematic review and meta-analysis. J. Psychopharmacol. 2015, 29, 753–763. [CrossRef]
[PubMed]
64. Stonehouse, W. Does consumption of LC omega-3 PUFA enhance cognitive performance in healthy
school-aged children and throughout adulthood? Evidence from clinical trials. Nutrients 2014, 6, 2730–2758.
[CrossRef]
65. Ruottinen, S.; Lagstrom, H.K.; Niinikoski, H.; Ronnemaa, T.; Saarinen, M.; Pahkala, K.A.; Hakanen, M.;
Viikari, J.S.; Simell, O. Dietary fiber does not displace energy but is associated with decreased serum
cholesterol concentrations in healthy children. Am. J. Clin. Nutr. 2010, 91, 651–661. [CrossRef]
66. Nelson, K.B.; Grether, J.K.; Croen, L.A.; Dambrosia, J.M.; Dickens, B.F.; Jelliffe, L.L.; Hansen, R.L.;
Phillips, T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental
retardation. Ann. Neurol. 2001, 49, 597–606. [CrossRef]
67. Pan, W.; Banks, W.A.; Fasold, M.B.; Bluth, J.; Kastin, A.J. Transport of brain-derived neurotrophic factor
across the blood-brain barrier. Neuropharmacology 1998, 37, 1553–1561. [CrossRef]
68. Matthews, V.B.; Astrom, M.B.; Chan, M.H.; Bruce, C.R.; Krabbe, K.S.; Prelovsek, O.; Akerstrom, T.; Yfanti, C.;
Broholm, C.; Mortensen, O.H.; et al. Brain-derived neurotrophic factor is produced by skeletal muscle
cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase.
Diabetologia 2009, 52, 1409–1418. [CrossRef]
69. Chaldakov, G.N.; Tonchev, A.B.; Aloe, L. NGF and BDNF: From nerves to adipose tissue, from neurokines to
metabokines. Riv. Psichiatr. 2009, 44, 79–87.
Nutrients 2019, 11, 620 16 of 16
70. Sung, K.H.; Chung, C.Y.; Lee, K.M.; Cho, B.C.; Moon, S.J.; Kim, J.; Park, M.S. Differences in Body Composition
According to Gross Motor Function in Children With Cerebral Palsy. Arch. Phys. Med. Rehabil. 2017, 98,
2295–2300. [CrossRef]
71. Sullivan, P.B.; Juszczak, E.; Bachlet, A.M.; Lambert, B.; Vernon-Roberts, A.; Grant, H.W.; Eltumi, M.;
McLean, L.; Alder, N.; Thomas, A.G. Gastrostomy tube feeding in children with cerebral palsy: A prospective,
longitudinal study. Dev. Med. Child Neurol. 2005, 47, 77–85. [CrossRef]
72. Caselli, T.B.; Lomazi, E.A.; Montenegro, M.A.S.; Bellomo-Brandao, M.A. Comparative study on gastrostomy
and orally nutrition of children and adolescents with tetraparesis cerebral palsy. Arquivos Gastroenterol. 2017,
54, 292–296. [CrossRef] [PubMed]
73. Day, S.M.; Strauss, D.J.; Vachon, P.J.; Rosenbloom, L.; Shavelle, R.M.; Wu, Y.W. Growth patterns in a
population of children and adolescents with cerebral palsy. Dev. Med. Child Neurol. 2007, 49, 167–171.
[CrossRef] [PubMed]
74. Morais, M.B.; Vitolo, M.R.; Aguirre, A.N.; Fagundes-Neto, U. Measurement of low dietary fiber intake as a
risk factor for chronic constipation in children. J. Pediatr. Gastroenterol. Nutr. 1999, 29, 132–135. [CrossRef]
75. Vande, V.S.; Van, R.K.; Van, W.M.; De, B.R.; Van, B.S. Constipation and fecal incontinence in children with
cerebral palsy. Overview of literature and flowchart for a stepwise approach. Acta Gastroenterol. Belg. 2018,
81, 415–418.
76. Andrew, M.J.; Parr, J.R.; Sullivan, P.B. Feeding difficulties in children with cerebral palsy. Arch. Dis. Child
Educ. Pract. Ed. 2012, 97, 222–229. [CrossRef]
77. Fardy, P.S.; White, R.E.; Haltiwanger-Schmitz, K.; Magel, J.R.; McDermott, K.J.; Clark, L.T.; Hurster, M.M.
Coronary disease risk factor reduction and behavior modification in minority adolescents: The PATH
program. J. Adolesc. Health 1996, 18, 247–253. [CrossRef]
78. Eliakim, A.; Barstow, T.J.; Brasel, J.A.; Ajie, H.; Lee, W.N.; Renslo, R.; Berman, N.; Cooper, D.M. Effect of
exercise training on energy expenditure, muscle volume, and maximal oxygen uptake in female adolescents.
J. Pediatr. 1996, 129, 537–543. [CrossRef]
79. Trevino, R.P.; Yin, Z.; Hernandez, A.; Hale, D.E.; Garcia, O.A.; Mobley, C. Impact of the Bienestar school-based
diabetes mellitus prevention program on fasting capillary glucose levels: A randomized controlled trial.
Arch. Pediatr. Adolesc. Med. 2004, 158, 911–917. [CrossRef]
80. Sharma, V.K.; Subramanian, S.K.; Radhakrishnan, K.; Rajendran, R.; Ravindran, B.S.; Arunachalam, V.
Comparison of structured and unstructured physical activity training on predicted VO2max and heart
rate variability in adolescents—A randomized control trial. J. Basic Clin. Physiol. Pharm. 2017, 28, 225–238.
[CrossRef]
81. Satish, V.; Rao, R.M.; Manjunath, N.K.; Amritanshu, R.; Vivek, U.; Shreeganesh, H.R.; Deepashree, S. Yoga
versus physical exercise for cardio-respiratory fitness in adolescent school children: A randomized controlled
trial. Int. J. Adolesc. Med. Health 2018. [CrossRef]
82. Walther, C.; Gaede, L.; Adams, V.; Gelbrich, G.; Leichtle, A.; Erbs, S.; Sonnabend, M.; Fikenzer, K.; Korner, A.;
Kiess, W.; et al. Effect of increased exercise in school children on physical fitness and endothelial progenitor
cells: A prospective randomized trial. Circulation 2009, 120, 2251–2259. [CrossRef] [PubMed]
83. McManus, A.M.; Masters, R.S.; Laukkanen, R.M.; Yu, C.C.; Sit, C.H.; Ling, F.C. Using heart-rate feedback to
increase physical activity in children. Prev. Med. 2008, 47, 402–408. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
